# Weijiu Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/weijiu-biotechnology

- Industry: Biopolymers
- Headquarters: Suzhou, China
- Latest round: Series A (Jan 6, 2022)
- Investors on record: 4

## About

Established in 2021 and based in Suzhou, China, Weijiu Biotechnology is a targeted drug developer that focuses on the research and development of cell therapy. The company founder by 5Y Capital and Dr. Hongjian Zhang.

The company focuses on the research and development of therapy for age-related debilitating diseases caused by inflammation and tissue fibrosis.

Following the funding in 2022, the company plans to focus on building development team and technology platform.

## Funding rounds

- Series A, Jan 6, 2022 — Yonghua Capital, Ming Bioventures, Firstlight Capital, Elikon Venture

## Investors

- Yonghua Capital (https://capitalatlas.ai/funds/yonghua-capital) — Series A
- Ming Bioventures (https://capitalatlas.ai/funds/ming-bioventures) — Series A
- Firstlight Capital — Series A
- Elikon Venture (https://capitalatlas.ai/funds/elikon-venture) — Series A